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38 Single-use technologies, in particular disposable bioreactor bags, have become integral 
 
39 within the biopharmaceutical community. However, safety concerns arose upon the 
 
40 identification  of  toxic  leachable  compounds  derived  from  the  plastic  materials. 
 
41 Although  the  leachable  bis(2,4-di-tert-butylphenyl)-phosphate  (bDtBPP)  has  been 
 
42 previously  shown  to  inhibit  CHO  cell  growth,  it  is  critical  to  determine  if  other 
 
43 compounds like this are still present in subsequent generations of films for industrial 
 
44 application. This study compares the performance of CHO cells, CHO-K1 and CHO- 
 
45 DP12, cultured in media conditioned in an older single-use bioreactor (SUB) film (F-1) 
 
46 and a newer generation film (F-2) from the same vendor. CHO cells cultured in media 
 
47 conditioned for 7 days in the F-1 film demonstrated significantly reduced growth and 
 
48 antibody productivity profiles when compared to controls and media conditioned for 
 
49 the same time period in the newer F-2 film. Proteomic profiling of CHO cells cultured in 
 
50 the  F-1  conditioned  media  identified  differentially  expressed  proteins  involved  in 
 
51 oxidative  stress  response  as  well  as  compromised  ATP synthesis.  These  potentially 
 
52 metabolically compromised cells exhibited reduced oxidative phosphorylation activity 
 
53 as well as lower glycolytic metabolism, characteristic of slower growing cells. Non- 
 
54 volatile and metal leachables analysis of film extracts by LC-MS revealed a reduction in 
 
55 the abundance of the analysed leachates from F-2 films when compared to F-1 films 
 
56 including bDtBPP, potentially explaining improved CHO cell growth in F-2 conditioned 
 
57 media.  Furthermore,  in  vitro  endocrine  disruptor  testing  of  the  known  leachable 
 
58 revealed this molecule to possess the potential to act as an androgen antagonist. This 
 
59 study  demonstrates  an  improvement  in  the  materials  composition  used  in  modern 
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69 1. Introduction 
 
70 With the emergence of novel bio-therapeutics, the advent of bio-similars and the increasing 
 
71 number of  lead molecules  within the  developmental  pipelines,  the notion  of individual 
 
72 manufacturing sites being constructed at a cost of ~€1 billion for every newly approved 
 
73 product is not sustainable 1. Increasing the flexibility of these manufacturing sites leading to 
 
74 the introduction of multi-drug facilities has been accomplished in certain cases through the 
 
75 implementation and integration of single-use disposable technology in place of or in parallel 
 
76 with   existing   stainless   steel,   hard-piped   production   platforms.   Applying   single-use 
 
77 technology  to  the  bioprocessing  pipeline  carries  with  it  a  cohort  of  potential  benefits 
 
78 including  reduced  CapEx  of  up  to  75%,  elimination  of  clean-in-place/steam-in-place 
 
79 treatments, thereby reducing operational costs, as well as minimising the environmental 
 
80 carbon footprint 2,3. Although the size limitations of SUBs (2,500L) does not compete with 
 
81 their stainless steel bioreactor counterparts (10-25k L), continuous bioprocessing, perfusion- 
 
82 based continuous bioproduction, upstream seed trains and mixed-use facilities in addition to 
 
83 buffer/media holding are all key advantages supported by single-use systems 4. 
 
84 The Chinese hamster ovary (CHO) cell is the predominant cell line used in the production of 
 
85 recombinant therapeutic proteins for the last 3 decades 5. Advancements in the areas of cell 
 
86 line development, bioprocess design and media composition has allowed for the multi- 
 
87 gram/L titres that we routinely see today, opposed to the mg/L of the 1980s. Pragmatically, 
 
88 these low titres have contributed to the requirement of large-scale fermenters that remain the 
 
89 standard unit of operation today. Despite the limitation in SUB size, further boosting the g/L 
 
90 titres from CHO cultures could mediate similar outputs from SUB batch cultures compared to 
 
91 large-scale SS bioreactors thereby potentially making the implementation of these scale-down 
 
92 systems more tangible 6. Of course with novel and more bespoke biologics being developed, 
 
93 difficult-to-express proteins are a constant challenge to the industry and remain a driving 
 
94 force for the generation of more sophisticated production CHO cell lines via approaches such 
 
95 as microRNA engineering 7, genetic knockouts 8, removing unnecessary genomic burdens 9 
 









One major concern associated with SU technology within the biomanufacturing space is the 
lack of clarity surrounding the leachable profiling from these predominantly polyethylene- 
based plastics. Previous reports with regards to the interaction of these plastics with media 









































chemical transformations introducing potentially toxic leachables into the culture media 
raises further concerns relating to any new material entering the bioprocessing pipeline. 
Routinely, additives are required for efficient processing and manufacturing of the plastic 
films such as the secondary anti-oxidant Irgafos® 168 which upon gamma-irradiation 
becomes oxidised and subsequently breaks down to leach degradation products into the 
culture media 12. The optimal culture environment within the bioreactor is critical to CHO 
cell performance and can be compromised by these leachable compounds that can be 
potentially toxic. For example, bis(2,4-di-tert-butylphenyl)-phosphate or bDtBPP was 
initially reported by Hammond and colleagues in 2013 13. Originating from the secondary 
anti-oxidant Irgafos® 168 or tris(2,4-di-tert-butylphenyl)-phosphite, bDtBPP was reported to 
inhibit cell growth in a variety of proprietary CHO cell lines at concentrations ranging from 
0.12-0.73 mg/L 14. More recently, studies from our group found this leachate to be toxic at far 
lower concentrations than previously reported (0.035-0.1 mg/L) 15 which fall within the 
concentration range that has been observed to leach and accumulate under ambient conditions 




























Leachable components such as bDtBPP have been reported to negatively impact cell culture 
performance not only in terms of growth/viability, but also titre or product quality 16. 
Although it would be advantageous to know the material composition so that potential causes 
may be evaluated, this information is usually not completely available from manufacturers. 
Also, due to the complexity of the bag manufacturing process, it is difficult to determine the 
exact composition of most bag films. However, it is known that degradation of the polymers 
and additives in SUBs occur most significantly during high-energy processes, namely 
sterilization 17 and film extrusion 18, which may produce degradation products such as 
bDtBPP, whose potential effects on cells maybe completely overlooked. This reality, 
combined with the low concentrations reported to elicit negative effects on cell growth makes 
it paramount that the appropriate solvent systems and analytical techniques for extractables 
and leachables (E&Ls) screening are being implemented that are sensitive enough to detect 












Increased understanding and characterisation of both the leachables profile from SUBs and 
their effects on cells is needed. At present, there are some standardised cell culture tests 
available 21,22 to assess the biocompatibility and safety of production cell lines 22,23, which 
will assist both bag manufacturers in developing and qualifying new bag films, and end-users 


















show different sensitivities to leachables components 22, developing widely applicable cell 
culture tests is not a trivial exercise, but it would, however, be desirable, so that vendors and 
































In addition, besides cell culture tests, plastic films used in biomanufacturing should also 
report leachables assessments in order to be considered fully characterised for their 
compatibility and safety in relation to cell culture performance as the cocktail of potential 
leachates other than bDtBPP could pose a problem. Although there is now a greater 
awareness of the use of single-use components in biomanufacturing, a comprehensive 
characterisation at all levels, both biological and chemical, should be an inevitable 
requirement for these SUBs to be available in the market. A large-scale assessment of E&Ls 
from 34 single-use plastic films used in cell cultivation has highlighted that the spectrum of 
E&Ls has changed due to the introduction of new types of polymers as well as manufacturing 
changes 20, whose potential biological effects should be addressed. In view of this, new 
regulations and standardised guidelines should be established by official institutions such as 
the Food and Drug Administration (FDA) and United States Pharmacopeia (USP), working in 
collaboration with industry groups such as BioProcess Systems Alliance (BPSA), the 
Parenteral Drug Association (PDA), the Product Quality Research Institute (PQRI), Dechema 






























In this study we performed a comprehensive examination of the impact of newer materials on 
both the leachables profile as well as the influence these materials had on CHO cell growth. 
Two generations of single-use films from the same vendor were chosen, a newer generation 
film (F-2) that was designed with lower levels of Irgafos® 168 compared to one of its 
predecessors (F-1). This strategy used by bag manufacturers would ultimately reduce the 
amount of the toxic bDtBPP that could potentially leach into the contacting media. Culture 
media was conditioned in each film as a means to capture the leachates derived from each 
plastic with subsequent growth profiling of two CHO cell lines. Leachable profiling of these 
two films in conjunction with cell-based assays using the same conditioned media afforded 
the ability to directly compare cellular performance and leachables content with particular 
emphasis on changes within the identified leachates, keeping known toxic leachables like 
bDtBPP in mind. This work also provides information about other sensitive tests that might 
be included with a view to the development of standardised culture cell tests that would 




















2. Materials and Methods 
 












Materials from two model generations of the same brand of SUBs (F-1 and F-2) were 
evaluated. These were multilayer films containing linear low density polyethylene as the fluid 
contact layer and ethylene-vinyl acetate as the gas barrier and outer layers. The model F-1 is 
an old version of this film while F-2 is a more recent version. 
 

































F-1 and F-2 SUBs (10 L total volume) were incubated with 2 L of the chemically defined 
BalanCD® CHO Growth A media (Irvine Scientific®) in the presence of 1% 
penicillin/streptomycin solution (Sigma–Aldrich). Sealed bioreactors were incubated on a 
Biostat® rocking motion incubator (Sartorius); temperature was set at 37 °C and the 
incubation was carried out for a duration of 3 or 7 days. To ensure good mixing and complete 
contact with bioreactors films, no inflation was used during the incubation and optimum 
speed and max rotation angle were used thus minimizing foam formation. Negative controls 
were generated, incubating 2 L of media in the presence of 1% penicillin/streptomycin in pre- 
rinsed and autoclaved grade A glass bottles, using the same conditions for incubation. 
Additionally, the same tubing was used to fill the bags as was used to fill the bottles for 
consistence purposes. Incubation with SUBs was performed in triplicate using bags from the 
same production lot. Negative controls were generated in triplicate as well. At the end of 
incubation time, all media samples were stored in the original plastic bottles at 4 °C. The 
labile component L-glutamine (Thermo Fisher Scientific) was added to the media after 
conditioning and just prior to setting up cell cultures. 
 








A parental non-producing CHO-K1 (ATCC® CCL-61TM) and an IgG-producing CHO-DP12 
(ATCC® CRL-12445TM Clone #1934) cell line was routinely cultured in chemically defined 




































clumping agent 2% polyvinyl alcohol. CHO-DP12 cells were maintained stable by pulsing, 
every 3 passages, with 200 nM of methotrexate (Sigma-Aldrich). Cell assays were inoculated 
at a starting cell density of 2 x 105 cells/mL in a 5 mL volume in a 50 mL filtered-topped tube 
(Helena BioSciences Europe) and maintained under ambient culture conditions of 37°C, 5% 
CO2 and 170 rpm. Viable cell density and cellular viability was assessed using a benchtop 
flow cytometer, Guava EasyCyte 5HT system (Millipore, Billerica, MA) in combination with 
the ViaCount assay (Millipore) as per manufacturer‟s specifications. Additionally, metal ion 
screening was performed using the following metal salts; Lead Nitrate, Silver Nitrate, 
Nickle(II) Chloride Hexadydrate, Sodium Molybdate dihydrate and Aluminium Chloride 
(Sigma-Aldrich), all dissolved in water and screened at a concentration of 1 mg/mL based on 
the molecular weight of the metal and not the salt. 
 












CHO-DP12 culture supernatants were collected by centrifugation at 1,000 x g for 5 min, the 
IgG containing supernatant was decanted and samples were diluted appropriately for each 
time point in diluent buffer. The ELISA work-flow was carried out in accordance with the 
manufacturer‟s specifications (Bethyl Laboratories). 
 























Non-targeted analyses were performed for identification of non-volatile leachables by LC- 
MS. Extracts were treated using DLLME 25 to remove surfactants and other matrix 
components present in the media that could cause ion suppression. HRAM full-scan MS 
analyses was performed on a Thermo Scientific™ UltiMate™ 3000 RS coupled to a Thermo 
Scientific™ Q Exactive™ Plus mass spectrometer with HESI-II interface 20. Resulting 
HRAM data were processed with Compound Discoverer™ 2.0, followed by automatic online 
library search against mzCloud.org advanced mass spectral database (HighChem) and 
ChemSpider (Royal Society of Chemistry), as well as a local E&L compound database. Mass 
Frontier 7.0™ software was used to determine most probable structures if several options for 
components were returned. For each proposed structure, the „Fragments and Mechanisms‟ 































the HighChem Fragmentation Library™ searching. A high degree of correlation between 
 
predicted and experimental fragments was required to confirm the proposed structure. 
 
A multi-element determination was also performed on the extracts by ICP-MS. Extracts were 
acidified with a mixture of 2% (v/v) HNO3 and 0.5% (v/v) HCl, in 1:9 sample/acid (v/v) prior 
to analysis. All 30 analytes, 75As, 111Cd, 202Hg, 208Pb, 7Li, 52Cr, 60Ni, 63Cu, 118Sn, 121Sb, 137Ba, 
27Al, 55Mn, 56Fe, 66Zn, 51V, 59Co, 78Se, 95Mo, 101Ru, 103Rh, 105Pd, 107Ag, 189Os, 193Ir, 195Pt, 
197Au, 205Tl, 88Sr, and 209Bi, were measured with a Thermo Scientific™ iCAP™ RQ ICP-MS, 
 
according to a previous study 20. Elemental concentration was determined using calibration 
curves from multi-elemental standards. 
 






















2.6.1 Cell culture 
 
All cell lines were grown in 75 cm2 tissue culture flasks (Nunc, Roskilde, Denmark) at 37°C 
with 5% CO2 and 95% humidity. The human adrenal carcinoma (H295R, ATCC) cell line 
was routinely cultured in H295R cell culture medium containing Dulbecco's modified Eagle 
medium (DMEM, Life Technologies) with Ham‟s F-12 nutrient mixture (1:1) supplemented 
with 1% ITS + Premix (BD Biosciences) and 2.5% NuSerum (BD Biosciences). The H295R 
cells were seeded in H295R assay media composed of DMEM with Ham‟s F-12 nutrient 
mixture (1:1) supplemented with 1% ITS + Premix and 2.5% charcoal stripped serum (Sigma-
Aldrich). 
 





















Four reporter gene cell lines were previously developed by transforming human mammary 
gland cell lines with the luciferase gene under the control of a steroid hormone inducible 
promotor as described in Willemsen et al 26. The TARM-Luc cell line is specific for the 
detection of androgens and progestagens, MMV-Luc cell line for oestrogens, TM-Luc for 
progestagens and TGRM-Luc for glucocorticoids and progestogens 27. These transformed cell 
lines were routinely cultured in cell culture medium containing DMEM and 10% foetal 
bovine serum. DMEM without phenol red was used when culturing the MMV-Luc cell line. 
RGA's were carried out in assay media composed of DMEM and 10% hormone depleted 
serum as previously described by Frizzell et al. 28. Briefly, cells were seeded at a 















well plates (Greiner, Bio-One, Frickenhausen, Germany) and incubated for 24 hours at 37 ºC 





































After 24 hours, bDtBPP and the relevant steroid hormone standards dissolved in DMSO was 
added to the cells at a final DMSO concentration of 0.1%. The final concentrations of 
bDtBPP during  cell  exposure  was 0.005,  0.025,  0.035,  0.05,  0.1 and 0.25 μg/mL.  The 
positive controls were: 1.36 ng/mL 17b-estradiol (MMV-Luc), 14.5 ng/ml testosterone 
(TARM-Luc), 157 ng/mL progesterone (TM-Luc) and 181 ng/mL cortisol (TGRM-Luc). A 
solvent control was also included for each cell line (0.1% v:v DMSO in media). Antagonist 
tests were carried out by incubating bDtBPP (0.005, 0.025, 0.035, 0.05, 0.1 and 0.25 μg/mL) 
with the relevant positive control for the cell line being tested. The cells were incubated for 
48 h, the supernatant discarded and the cells washed once with 200 μl PBS. The cells were 
lysed by adding 25 μL cell lysis buffer (Promega, Southampton, UK) to each well. Finally, 
100 μl luciferase substrate (Promega, Southampton, UK) was injected into each well. 
Luciferase activity was measured using a Mithras Multimode Reader (Berthold, Other, 
Germany) and the response compared to that of the solvent and positive controls. RGAs were 
performed in triplicate for each experimental point and in three independent exposures. The 




























2.6.3 H295R steroidogenesis assay 
 
The H295R cell line was obtained from the American Type Culture Collection LGC 
Standards. The assay was carried out as described previously 29. Briefly, the H295R cells 
were seeded at a concentration of 3 x 105 cells/mL, 1 mL/well, into 24-well cell culture plates 
(BD Biosciences, Bedford,  MA, USA). The  cells were allowed  to attach for 24 hours. 
Following cell attachment, the media was replaced with fresh H295R assay media containing 
the test compounds (bDtBPP 0.005, 0.025, 0.035, 0.05, 0.1 and 0.25 μg/mL) dissolved in 
DMSO at a final concentration of 0.1% (v:v). Forskolin 10 μM (FSK10) was used as a 
positive control and 0.1%, v: v DMSO in media as a solvent control in triplicate. Forskolin 
has been shown to act as general inducer of steroidogenesis in the H295R cell line via 
activation of cAMP pathways, resulting in elevated levels of oestradiol, testosterone and 
progesterone 29. After 48 hours of exposure, media was collected from each well and stored at 


















previously 27. All experimental points in the H295R assay were performed in triplicate and 
repeated in three independent exposures. The AlamarBlue® cell viability assay was 










































2.6.4 Hormone detection and quantification 
 
The steroid hormones oestradiol, testosterone, progesterone and cortisol levels in the media 
were quantified in duplicate by highly specific ELISA assays (DRG Diagnostics, Marburg, 
Germany). These highly specific kits are based on the principle of competitive binding and 
are intended for the quantitative in vitro diagnostic measurement of oestradiol (0-2000 
pg/mL), testosterone (0-16 ng/mL), progesterone (0-40 ng/mL) and cortisol (0-800 ng/mL), 
with sensitivities of 10.60 pg/mL, 0.083 ng/mL, 0.045 ng/mL and 2.5 ng/mL respectively 
(DRG Diagnostics, 2016; DRG Diagnostics, 2009; DRG Diagnostics, 2007; DRG 
Diagnostics, 2006). In order to assess their suitability for measuring the steroid hormones, 
oestradiol, testosterone, progesterone and cortisol standard curves were prepared in H295R 
cell cultures. The ELISA was validated for measuring the steroid hormones in this culture 
medium. All other steps in the ELISAs were carried out in accordance with the 
manufacturer's instructions (DRG Diagnostics, 2016; DRG Diagnostics, 2009; DRG 
Diagnostics, 2007; DRG Diagnostics, 2006). The intra-assay coefficients of variation were 
less than 10%. Each ELISA plate contained a standard curve, solvent control, positive control 
and the test compound bDtBPP concentrations. The optical density was measured at 450 nm 
wavelength using a Sunrise spectrophotometer (TECAN, Switzerland). The mean absorbance 
obtained from each standard was plotted against its concentration using dose-response curves 
generated with GraphPad PRISM 5 software. 
 














As well as visual inspection of the RGA and H295R cells under the microscope to evaluate 
cell morphology and attachment, cell viability assays were performed in parallel to the assays 
to check for any toxic effects of the concentrations of bDtBPP which the various cell lines 
were exposed to. For the H295R and RGA cell lines, the AlamarBlue® assay 30 and MTT 
assay 31, respectively, was carried out as reported previously. 
 
































All experimental points in the H295R assay, RGAs and cell viability assays were performed 
in triplicate and repeated in three independent exposures. All values shown are expressed as 
mean ± standard error of the mean of the three independent exposures (n=3). Data were 
analysed using Microsoft Excel and Graphpad PRISM 5.01 software. A one way analysis of 
variance (ANOVA) and Dunnett's Multiple Comparison Test was used to determine 
significant differences between the treatments and the corresponding controls. The mean 
concentrations were tested for significant difference at the 95% confidence level. The 

















































Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured 
using the cell metabolic analyser Seahorse XF96 (Agilent technologies) according to the 
manufacturer's instructions. 2x105 cells were cultured in 5 mL of media conditioned in F-1, 
F-2 and Control glass bottles and cultured for 96 hours at 37 ºC. A Seahorse XF96 cell 
culture plate was previously coated with Corning Cell-Tak cell and tissue adhesive 
(Corning™, 22.4 μg/mL) and incubated for 1 hour in a 37 ºC non-CO2 incubator. 
Conditioned media were replaced by unbuffered Seahorse XF media for Phenotype assays 
and with Buffered Seahorse XF media (without phenol red) for glycolytic rate assays. In both 
cases, Seahorse XF media were supplemented with 10 mM glucose, 1 mM pyruvate and 2 
mM glutamine and pH adjusted to 7.4. Finally, 2 x 10΀ viable cells/well were pelleted, 
re- 
suspended in the corresponding Seahorse XF media and plated into the previously coated 
plate  (50uL  containing  400  cells/μL  per  well,  2  x  10΀  viable  cells/well).  Plates  
were 
centrifuged at 300 g for 1 minute, incubated at 37 °C in a CO2-free incubator for 30 min and 
 
150 μL of Seahorse media were carefully added to each well, followed by a 30 minute 
incubation. Three real-time measurements of OCR and ECAR were directly measured (basal 
readings) and after injection of different mitochondrial inhibitors or glycolytic modulators. 
For phenotypic assays, the cells were treated with optimized concentrations of oligomycin (1 















































d with optimized concentration of rotenone + Antimycin A (0.5 μM) and 2-deoxy-D-glucose 

























rotenone + antimycin A and 2-deoxy-D-glucose concentrations were optimized according to 
the manufacturer's instructions. The corresponding assay, phenotype assay or glycolytic rate 
assay were run using the Seahorse XF-96 analyser pre-programmed templates for these 
assays. 
 




















































Cell pellets from the CHO-K1 and CHO-DP12 cell lines treated with BalanCD® Growth A 
media conditioned in both F-1 and F-2 films for 7 days as well as negative control media 
were lysed in a buffer containing 7 M urea, 2M Thiourea, 4% CHAPS and 30 mM Tris at pH 
8.5. Protein concentration was determined using a QuickStart Bradford protein assay (Biorad) 
and 100 μg of each sample was prepared for quantitative proteomic analysis. Protein samples 
were prepared as previously described using the Filter Aided Sample Prep (FASP) method 
and C18 peptide purification 32,33. Nano LC-MS/MS was performed using a Dionex Ultimate 
3000 nanoRSLC (Thermo Scientific) coupled in-line to an Orbitrap Fusion Tribrid mass 
spectrometer (Thermo Scientific). LC-MS/MS methods were applied as previously described 
34. Protein identification was achieved using Proteome Discoverer 2.2 with Sequest HT and 
 
MASCOT algorithms. Data was searched against the NCBI Chinese Hamster Ovary 
(Cricetulus griseus) protein database downloaded in November 2017 containing 24,906 
sequences. Quantitative label-free  data analysis was performed  using Progenesis QI for 
Proteomics (version 2.0, Nonlinear Dynamics, Waters) essentially as described by the 
manufacturer. Protein identifications from Proteome Discoverer were imported into 
Progenesis QI for Proteomics for differentially expressed proteins. Proteins were considered 
differentially expressed if they passed the following criteria (i) a minimum of 2 peptides 
contributing to a protein identification (ii) an ANOVA p-value score <0.05 between sample 















































We performed biocompatibility profiling of two films sourced from the same vendor; one of 
which was an older film (F-1) and one a more modern film (F-2) of the same design. To 
assess the potential cellular toxicity of leachable compounds derived from newly developed 
materials as opposed to single molecule screening, as in the case bDtBPP 15, we conditioned 
chemically defined media using SUBs made of the two referred films, F-1 and F-2. The 
cocktail of other leachates and the array of concentrations that each compound accumulates, 
could all play a role in toxicity. These two films were chosen to determine, in an extreme 
case of a poor performing SUB versus a good performing SUB, what the influence to CHO 




















In keeping with  our  previous  study 15,  both the  parental  CHO-K1  and  the  monoclonal 
antibody (mAb)-producing CHO-DP12 cell lines were evaluated for compatibility with both 
film-conditioned media. Culture media was conditioned in both F-1 and F-2 films over a 7 
day time course to capture the full complement of potential plastic sub-components to leach 
into the culture media and to do so at concentrations most likely to elicit toxic effects. 
Following on from this, the same basal culture media was carried through an identical 
conditioning process in both F-1 and F-2 films for a 3 day time course. This more modest 
conditioning time was selected to reflect both previously published conditioning timelines 14 












CHO-K1 cells cultured in media conditioned for 7 days in the F-1 film demonstrated 
considerably reduced growth when compared to control cultures (Fig. 1A). This growth 
inhibitory F-1 media did not appear to negatively impact CHO cell viability (Fig. 1B). In 
contrast, CHO-K1 cells cultured in F-2 film conditioned media exhibited no adverse growth 

























CHO-DP12 cell line was subjected to the same 7 day conditioned media, the F-1 film was 
observed to reduce cell growth with no deleterious effects on culture viability when 
compared to controls (Fig. 1E and F). A ~60% reduction in mAb production (Fig. 1G) was 
observed in the case of F-1 cultured CHO-DP12 cells. As in the case of CHO-K1s, CHO- 
DP12 cells cultured in the F-2 conditioned media behaved similar to the controls while 
















We next generated conditioned media using both F-1 and F-2 films for a time course of 3 
days. CHO-K1 cells cultured in conditioned media from both F-1 and F-2 films demonstrated 
comparable growth and viability to control media (Fig. 2A-D). In the case of CHO-DP12 
cells, cell growth, viability and productivity remained similar to that of controls for both F-1 
(Fig. 2E-G) and F-2 (Fig. 2H-J) films. 
 











From the cell toxicity data, it is evident that conditioned media generated from the F-1 film 
over a 7-day time course is inhibitory to CHO cell growth and productivity when compared 
to a more modern film conditioned for the same time. For this reason, we performed label- 
free LC-MS/MS proteomic profiling on CHO-K1 and CHO-DP12 cells cultured in both films 














Label-free LC-MS/MS on CHO-DP12 and CHO-K1 cells cultured in the toxic F-1 
conditioned media and sampled after 96 hours revealed 155 differentially expressed (DE) 
proteins in both CHO-DP12 and CHO-K1 cells (Sup. Table 1) with 35 common across both 
cell lines (Fig. 3A). Qualitatively, 4667 and 5092 proteins were identified in CHO-DP12 and 
CHO-K1 cells, respectively (Sup. Table 2), cultured in F-1 conditioned media with Table 1 














One interesting group of proteins that were down-regulated in both CHO-DP12 and CHO-K1 
cells exposed to F-1 film conditioned media were all components of the NADH 
dehydrogenase enzyme (Complex I), NDUFS2, NDUFS8, NDUFV1, and NDUFA10 of the 
mitochondrial electron transport system (ETS). Given this observation, we assessed 
mitochondrial function through the measurement of oxygen consumption rate (ECR) using a 

































consumption was reduced in CHO cells cultured in F-1 conditioned media where as normal 
mitochondrial activity was observed in cells cultured in F-2 conditioned media when 
compared to negative controls (Fig. 3B). When extracellular acidification rate (ECAR) of the 
culture media was determined, it was observed that slow growing CHO cultures from F-1 
conditioned media exhibited a reduced rate of extracellular media acidification when 
compared to F-2 conditioned media and negative controls (Fig. 3C). Gene-Ontology analysis 
based on DE proteins in CHO-K1 and CHO-DP12 cells cultured in F-1 film conditioned 
media revealed the enrichment for biological processes relating to oxidative stress and 
mitochondrial respiratory chain complexes (Table 2). Up-regulation of the mitochondrial 
Lon Protease (LONP1) was identified in F-1 cultured CHO cells which is a protein 

































When CHO-DP12 and CHO-K1 cells cultured in the non-toxic F-2 film conditioned media 
and subjected to proteomic analysis, it was interesting to observe 108 and 268 proteins DE in 
CHO-DP12 and CHO-K1 cells, respectively (Sup. Table 3). There were 19 DE proteins 
common to both cell types with two proteins demonstrating contrary expression patterns, 
glutathione synthetase and coatomer subunit alpha. When compared to the 35 common DE 
proteins from cells cultured in the toxic F-1 conditioned media (Table 1), there was 1 protein 
found to overlap between the non-toxic F-2 film and the toxic F-1 film, transferrin receptor 
protein 1 (TFCR), (Fig. 3A). However, although this common DE protein was found to be 
decreased in its expression in cells cultured in the toxic F-1 conditioned media, it was highest 
in its abundance in CHO-DP12 and CHO-K1 cells cultured in F-2 conditioned media. It is 
apparent from this study that media conditioned from a SUB film (F-2) that does not impact 
on CHO cell growth does still influence the cells proteome. It is not surprising that 
differential protein expression was observed for both films as leachables were present in both 
cases as the following analysis will demonstrate. 
 











Sixteen compounds with confirmed and confident identification from the media extracts by 
LC-MS are listed in Table 3. Twelve of the 16 compounds (75%) were present at higher 
levels in F-1 bags compared to F-2 (Fig. 4A), including 2 degradation products of 
Irgafos®168: bDtBPP, which has negative effects on CHO cells, as indicated in previous 




















1-amine (C12H27N) and cis-1,3-docosenic acid amide (Kemamide
® E ultra) (C22H43NO) were 
detected only in F-2 bags. Figure 4B and C shows LC chromatograms for F-1 and F-2 
extracts, where some leachables with higher concentrations in F-1 are highlighted, including 

















In general terms, the identified non-volatile compounds belong to different chemical classes 
and also perform different functions as components of plastic materials. Major extractable 
compounds identified can be classified as antioxidants and their degradation products, 
plasticisers, polymer-related compounds, as degradation products and building blocks, and 
residues from the polymerisation process, such as initiators and catalysts. The groups of 
compounds with specific functions that were identified in the samples are also reported in 
Table 3. Several of these compounds were already reported previously 36–38. Intact 






























The identified compounds were also structurally classified via Toxtree version 2.6.0 39 using 
the Cramer rules with extensions. Based on quantitative structure–activity  relationships 
(QSARs), the Cramer classification is a rules-based process that sorts compounds into three 
classes; Class 1 (low risk of toxicity), Class 2 (intermediate between 1 and 3), and Class 3 
(either no basis to presume safety or suggest significant toxicity). Additionally, the entire 
population of compounds was assessed by in silico QSAR analysis for their 
mutagenic/carcinogenic potential using the Benigni/Bossa rule base. The Cramer 
classifications and mutagenicity assessments were performed using the appropriate modules 
of Toxtree software. Results indicated that most leachables (75%) are quite toxic, being 
classified in Cramer Class 3 and only 25% were in Cramer Class 1. But nevertheless only 2 
compounds (13%) triggered an in silico alert for mutagenicity, which also belong to Cramer 
Class 3. The referred compounds, 2,(4 or 6)-toluendiamine and 2,4-dimethyl-aniline, are 
residues from the polymerization process, and have presumably the highest safety risks of the 














Regarding elemental analysis, only 9 elements of 30 were found in the samples (Table 3). As 
shown in Figure  4D, 4  of the 9  elements  (44%):  Ni, Ag, Sn, and Ba were at higher 
concentrations in F-1 bags, and the other 5 elements (56%): V, Mo, Cd, and Pb, showed the 
highest levels in F-2 bags, while Cu levels were similar in both SUBs. V and Cd were found 
only in F-2 bags, while Ba was only found in F-1 bags. The ICH Q3D guidelines 40 classify 























product, and also specify both daily doses and concentration limits of metallic impurities in 
pharmaceutical final products and in active pharmaceutical ingredients and excipients. 
According to these guidelines, the highest levels of Pb and Cd, Class 1 elements and the most 
toxic ones were found in F-2 films, followed by Mo and V that belong to Class 2A. Ag, also a 
toxic element (Class 2B) is the only element of concern that was found at higher 



































Interestingly, when a subset of metal ions (Ag, Pb and Ni) were screened in CHO-K1 and 
CHO-DP12 cells at a high concentration of 1 mg/L, similar to previous screening studies 13,15, 
Ag was found to be the only metal to elicit toxic effects on growth of both CHO-K1 and 
CHO-DP12 cells (Fig. 5A and C). Silver (Ag), previously categorised as a toxic element 
(Class 2B) was observed to be at a higher abundance in F-1 films than F-2 films (Fig. 4D). 
However, when lower concentrations of Ag were screened, the toxicity effects impacting 
CHO cell growth and productivity, in the case of the CHO-DP12s, was not apparent (Fig. 5B, 
D and E). Surprisingly, Pb (lead), despite being classed as Class 1 and highly toxic did not 
exhibit any negative effects on CHO cell growth and viability when screened at 1 mg/L and 
appeared to be higher in abundance in the non-toxic F-2 film compared to the F-1 film (Fig. 
5A and B). As concentration levels and the thresholds of toxicity would play a role in 
affecting cell growth, further investigation is needed to determine whether metals such as 
silver contributed to the toxicity of the F-1 conditioned media as well as determining the 
exact metal species present within the conditioned media as opposed to the metal salt used 
during toxicity screening. 
 



















Lastly, leachable compounds from plastic materials have long been on the radar in relation to 
their safety profiles to human health such as bisphenol A 41. Not only in the context of their 
potential toxicity to the bioprocess itself, leachables from the final container closure system, 
packaging components such as pre-filled syringes and/or processing equipment also pose a 
threat to the patient 42 if present in the active biopharmaceutical ingredient. Using H295R 
cells, a range of concentrations of bDtBPP previously observed to negatively impact CHO 
cell growth 15, 0.005-0.25 μg/mL, was tested in relation to its capacity to disturb hormone 
production or interact with a range of hormonal receptors. The production of a range of 


























or retarded by incubation with various concentrations of bDtBPP (Sup. Fig. 1). No agonsim 
was observed in the estrogen, androgen, glucocorticoid and progesterone receptors when 
tested by reporter gene assays (RGA). However, when bDtBPP was screened by co- 
incubation with various hormones, testosterone, estrogen, progesterone and cortisol, it was 
observed that between 0.1-0.25 μg/mL of bDtBPP acts as an androgen antagonist (Fig. 6B), 







































Shortly before the discovery of bDtBPP, a means of testing newly developed films for cell 
culture compatibility was published by Genentech, which monitored the growth of cells in 
media that had been stored in 13 different single-use bags 43. This study highlighted 4 viable 
bag film options, however, concluded that a “volatile or air-quenched compound, likely 
generated by gamma irradiation of the problematic bag film” to be the source of their poor 
performance in cell-based assays. Recently, Dorival-García et al., reported a novel solvent 
system for the optimised study of highly hydrophobic compounds of which bDtBPP falls 
under for the identification of potentially non-satisfactory films for cultivation of CHO cell 
lines 44. Critically, these studies were performed under realistic possible conditions and 
determine the milieu of leachables from SUBs that enter the growth media and potentially 
cause a threat to cell growth. In this instance, in the absence of a benchmark for a “good” 
performing bag, cell culture media were conditioned by incubation at 37°C in two SUBs 
made with different plastic films as a means to capture the full leachable profile derived from 
each film under normal processing conditions and compared to the corresponding control 
using glass bottles. Two conditioning times were selected in advance; a 7 day time course to 
best capture the cocktail of leachables derived from these two films in excessive 
concentrations and; a 3 day time course to capture leachable content over a more modest 














It was evident that cell culture media conditioned in the older film (F-1) was toxic to CHO 
cell growth with a negative impact on IgG productivity when incubated for 7 days prior to 
inoculation. This level of toxicity was not observed in the case of media conditioned in the 
more modern F-2 film for the same 7-day incubation with cultures performing similar to 
negative controls and fresh media controls. This suggests that changes have been made in the 








































reported data, the pre-requisite secondary anti-oxidant, Irgafos® 168, is the origin of the 
known toxic leachable bDtBPP upon gamma irradiation 45. Eliminating Irgafos® 168 as a 
material component during the extrusion process (e.g. high temperature, shear etc.) can 
dramatically affect polymer degradation 46. However, minimizing the concentration of 
Irgafos® 168 and thereby the amount of bDtBPP that can leach has been a proposed 
alternative for film development and process control 47, which is the case in these two films 
going from F-1 to F-2. Leachable testing of both F-1 and F-2 film extracts demonstrated that 
the leachate bDtBPP was present at far higher concentrations in the F-1 condition media 
compared to the more recent F-2 film (Fig. 4B and C), potentially contributing to the cellular 
toxicity observed in the case of F-1 cultured CHO cells. In relation to the abundance of its 
pre-requisite Irgafos® 168, this was not detected under any extraction conditions preventing 
us from concluding that reduced bDtBPP is a result of minimal Irgafos® 168  content. 
Evidence suggests that it may be degraded during the incubation step due to oxidation at high 








































Previous studies have demonstrated bDtBPP to leach at concentrations ranging from 0.025- 
 
0.11 mg/L in a panel of SUB films over a 4 day conditioning period 14. Our data indicates that 
a residency time period of 3 days may not be sufficient enough to leach toxic compounds 
such as bDtBPP to levels comparable to 7-days. Proteomic profiling of CHO-K1 and CHO- 
DP12 cells exposed to the toxic F-1 7 day conditioned media revealed several biological 
processes critical to bioprocess efficiency (Table 1). Reduced growth of both CHO cell lines 
in F-1 conditioned media exhibited a weakened capacity for ATP synthesis through 
diminished electron transport through the mitochondrial electron transport system as well as 
an increased response to oxidative stress. Gene ontology analysis of the DE proteins in both 
CHO-K1 and CHO-DP12 cells cultured in F-1 conditioned media supported this observation 
with enrichment for  biological processes associated with oxidative stress and oxidative 
phosphorylation (Table 2). This weakened mitochondrial activity was highlighted through 
the reduction in expression of a subset of proteins all involved in NADH dehydrogenase 
activity (NDUFS2, NDUFS8, NDUFV1 and NDUFA10) 51. This complex, composed of 47 
sub-units (7 mtDNA encoded/40 nDNA encoded), represents the main electron entry point of 
the ETS as well as contributing substantially to the formation of the proton gradient across 
the inner mitochondrial membrane, which drives ATP synthesis culminating in the 
consumption of oxygen and the generation of water 51. Interrogating this phenotype further 



























media displayed a reduced OCR when compared to negative controls and cells cultured in the 
non-toxic F-2 conditioned media. Previous studies have demonstrated that CHO cells under a 
med-high fed-batch culture process exhibited a reduce OCR in combination with a fast- 
growing phenotype when compare to controls 52. Furthermore, the extracellular acidification 
rate (ECAR) was also found to be reduced in F-1 cultured cells exhibiting impeded growth 
capacity when compared to F-2 cultured cells and negative controls (Fig. 3C). Acidification 
of the culture media is a result of lactate production through glycolytic metabolism and is a 




































Cells cultured in F-2 conditioned media maintained a similar glycolytic flux to negative 
control cells suggesting that the underlying cellular architecture (19 DE proteins common to 
both CHO-K1 and CHO-DP12s) that is influenced by the potential leachates derived from the 
F-2 film does not impact critical biological processes. Oxidative stress was another signature 
biological process evident in F-1 conditioned media-exposed cells with proteins such as 
LONP1 and VNN1 being increased in abundance. Previous spiking studies using bDtBPP 
alone revealed oxidative stress through the expression of heme oxygenase 1 (HMOX1) further 
supporting the presence of this leachate in F-1 film conditioned media 15, as shown by LC- 
MS. The mechanism of action of bDtBPP negatively impacting CHO cell cultures is 
unknown other than what is indicated through proteomic profiling. However, the chemical 
composition of bDtBPP itself gives this molecule potentially a high affinity for oxygen 
therefore scavenging dissolved oxygen within the media resulting in hypoxia, a biological 
process further highlighted in previous work through the expression of hypoxia upregulated 
protein 1 (HYOU1). A simple spiking study of bDtBPP versus a DMSO control in media 
resulted in an accelerated depletion of dissolved oxygen when monitored using the 
Oxygraph-2k respirometer (Data not shown), indicating the potential for this leachable and 


















Leachables analysis further highlighted a panel of compounds present at higher 
concentrations in the F-1 film compared to F-2 film extracts again suggesting reduced 
primary raw materials used in bag manufacturing such as in the case of Irgafos® 168 as 
indicated by the reduced concentration of bDtBPP (Fig. 3B and C). From a panel of trace 
metals screened, silver (Ag) was the only one found to be toxic to both CHO-K1 and CHO- 
DP12 cells at high concentrations of 1 mg/L. Despite its toxicity at such high concentrations, 
silver elicited no growth inhibitory effects at doses as high as 0.25 mg/L (Fig. 5A and C). 

























reduced but still present (Fig. 4D). The poor performance of CHO cells when cultured in F-1 
conditioned media could be as a result of the combined effects of toxic leachates such as 
bDtBPP and Ag, however, further investigation would be required to examine the exact 
concentrations of leachables that enter the media after 7 days and if these concentrations are 
in line with cell toxicity assays. It is also important to note that the metal salts used in this 
screen may not reflect the exact metal species that leaches from these plastic films but 







































Validating the safety profile of the F-2 film over its predecessor F-1 counterpart for CHO cell 
culture is an important step forward in progressing the adoption of this technology for 
recombinant protein drug manufacturing within the biopharmaceutical industry. However, 
from the perspective of human health, most plastic products release estrogenic chemicals 41 
highlighting the potential for endocrine disrupting leachates to be present within the media 
and possibly persisting through purification processes. We have demonstrated that the well- 
known leachate, bDtBPP, is considerably reduced in its abundance in the more recent film 
generation (F-2) but is still present. Using this as an example, it was evident upon screening 
at a range of concentrations (0.005-0.25 mg/L), as previously reported 15, that bDtBPP 
possessed the capacity to act as an androgen receptor antagonist (Fig. 6B). It has previously 
been reported that bDtBPP accumulates to levels ranging from 0.025-0.11 mg/L over 3-4 
days incubation under bioprocess-relevant conditions 14. Our data demonstrates that this 
leachate present in modern generations of films can potentially act as an endocrine disruptor 
at concentrations reported to leach and accumulate in media extracts. Leachable analysis in 
this present study was qualitative, allowing for normalised abundances between F-1 and F-2 
films and not exact concentrations. Regardless, the potential for additional leachables from 















Single-use technologies, in particular SUBs, are gaining wide-spread acceptance within the 
biomanufacturing space due to more recent generations of films being developed and a better 
understanding on the safety concerns around leachable materials. We have demonstrated that 
media conditioned in an older F-1 SUB film inhibited cell growth when compared  to 
controls. Contrary to this, cells cultured in media conditioned using a newer film generation, 
































































reduced mitochondrial activity as well as glycolytic metabolism in addition to oxidative 
stress, highlighted through proteomic analysis. Parallel leachable analysis on film extracts 
used for cell culture assays demonstrated that the abundance of most leachates was reduced 
when going from one generation to the next including the toxic compound bDtBPP as well as 
the potentially toxic metal silver (Ag). Other compounds were identified that were unique to 
the more recent film generation (F-2) which suggests that new material components are being 
used in film manufacturing and therefore must be subjected to E&L analysis as well as 
toxicology screening. As the pre-requisite component of bDtBPP, Irgafos® 168, was not 
detected in either F-1 or F-2 extracts, we were unable to definitively conclude that the 
reduced levels of bDtBPP leaching was due to reduced Irgafos® 168 starting material. 
Furthermore, in the case of the toxic F-1 film, there appears to be a time-dependency which 
allows leachables to accumulate to toxic levels in the case of 7 versus 3-day conditioning 
studies. This would suggest that older films like F-1 could be suitable for use in short batch 
runs such as 48-72 hour seed trains used in scale-up without compromising cell growth 
whereas longer fed-batch production processes may be more suited to newer films. Finally, 
after evaluating the safety profile of a modern single-use film for CHO cell culture, we 
demonstrated that leachables such as the well-known bDtBPP possess the capacity to act as 
an endocrine disruptor, in particular, an androgen antagonist. This would suggest that further 
studies should be performed to know, in more detail, the effects such leachates have on the 
endocrine system and the potential threat to patient safety. Studies such as this support the 
safe implementation of SUBs within the biopharmaceutical industry and demonstrate that bag 
manufacturers are tailoring plastic formulations to address past concerns over toxic 
leachables. Nevertheless, the lack of standardisation and regulation emphasises the necessity 
to further develop a toolkit for assessing the safety and biocompatibility of emerging films for 
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bDtBPP - bis(2,4-di-tert-butylphenyl)-phosphate, CHO – Chinese hamster ovary, DE – 
Differentially Expressed, E&Ls – Extractables and Leachables, mAb – Monoclonal antibody, 
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Figure 1: Impact of conditioned media from two single-use disposable bioreactor bags 
on the bioprocess-relevant phenotypes of CHO-K1 and CHO-DP12 cells. Cells were 
cultured in an 8-10 day batch process in chemically defined media (BalanCD CHO 
Growth A) and analysed every 2 days for cell density and culture viability using the 
Guava ViaCount Assay as well as for IgG production using ELISA. CHO-K1 cells 
cultured in media conditioned in the older F-1 film (A and B) and newer F-2 film (C and 
D) for 7  days. CHO-DP12 Cells cultured in same F-1 (E-G) and F-2 (H-I) media 
conditioned. Control cells were cultured in media conditioned for the same 7 day 
timeframe but done so in glass bottles. An additional control “Fresh BalanCD” was 
included which compares culture media not subjected to the conditioning process. (n = 














Figure 2: Impact of conditioned media from two single-use disposable bioreactor bags 
on the bioprocess-relevant phenotypes of CHO-K1 and CHO-DP12 cells. Cells were 
cultured in an 8-10 day batch process in chemically defined media (BalanCD CHO 
Growth A) and analysed every 2 days for cell density and culture viability using the 
Guava ViaCount Assay as well as for IgG production using ELISA. CHO-K1 cells 





















cells cultured in media conditioned in F-1 (E-G) and F-2 (H-I) films for 3 days Control 
cells were cultured in media conditioned for the same 3 day timeframe but done so in 
glass bottles. An additional control “Fresh BalanCD” was included which compares 























Figure 3: The number of both common and unique differentially expressed proteins 
identified through quantitative label-free LC-MS/MS proteomic analysis from CHO-K1 
and CHO-DP12 cells cultured in 7 day F-1 and F-2 film conditioned media and 
harvested 96 hours into culture for proteomic analysis are represented in the Venn 
diagram (A). Using the Seahorse FX96 analyser, CHO-K1 cells cultured in 7 day 
conditioned media in both F-1 and F-2 films were assessed for mitochondrial/TCA cycle 
activity by monitoring the oxygen consumption rate (OCR), B) as well as glycolytic 
metabolism through the assessment of the extracellular acidification rate (ECAR), C). 
Cells were harvested for analysis 96 hours into culture and compared to control 














Figure 4: A) Comparative chart for identified non-volatile leachables in both evaluated 
SUB models. Comparative LC chromatograms from (B) F-1 and (C) F-2 films. Some 
compounds that demonstrated higher levels in F-1 are highlighted, including bDtBPP, 
and details for these are shown in table 3. D) Comparative chart for identified elemental 
leachables from both evaluate SUB models. E) Comparative chart for the identified 
























Figure 5: Impact of various elemental leachables on the bioprocess-relevant phenotypes 
of CHO-K1 and the antibody-producing CHO-DP12 cell lines. Cells were cultured in 
chemically defined (BalanCD CHO Growth A) media spiked on day 0 with the various 
elemental metal (Al, Pb, Ni, Ag and Na) and harvested 96 hours into culture for growth 
and viability analysis using the Guava ViaCount Assay and IgG production using 
ELISA. Metals were dissolved in water and spiked at a concentration of 1 mg/L in both 
CHO-K1 (A) and CHO-DP12 (C) cells on day 0 of culture and assessed for growth and 
viability. Various concentrations of silver (Ag) ranging from 0.001-2 mg/L was spiked at 
day 0 in CHO-K1 (B) and CHO-DP12 (D) cultures and assessed for growth and 
viability. Additionally, in the case of CHO-DP12 cells, IgG productivity was assessed 
























Figure 6: Antagonist effects of bDtBPP (0.005 - 0.25 μg/ml) in the androgen and 
progestagen responsive TARM-Luc cell line. The responses measured are compared to 
the solvent control (0.2% DMSO) and the positive control (testosterone 288 ng/ml). 
Percentage responses are expressed as ±SEM for three independent exposures in 
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Table 1: Common Differentially Expressed proteins in CHO cells incubated in F-1 film 
conditioned media 
 
Gene I.D. UR/DR FCCHO-DP12 FCCHO-K1 Biological Process 
NDUFS2 DR 4.17 1.51 ATP synthesis 
NDUFS9 DR 2.55 1.70 Electron transport 
NDUFV1 DR 2.30 1.66 ATP synthesis 
NDUFA10 DR 2.17 1.68 Electron transport 
PCK1 UR 1.59 2.04 Glucose metabolism 
LONP1 UR 1.79 2.14 Oxidative stress 
VNN1 UR 1.51 1.62 Oxidative stress 
CHCHD1 UR 1.64 1.75 Mitochondrial translation 
elongation 
Abbreviations:  CHCHD1   –   Coiled-coil-helix-coiled-coil-helix  domain-containing  protein  2,  DR  – 
Downregulated, FC – Fold Change, LONP1 – Lon protease-like, NDUFS2 – NADH dehydrogenase iron- 
sulfur protein 2, NDUFA10 – NADH dehydrogenase 1 alpha sub-complex subunit 10, NDUFS9 – NADH 
dehydrogenase iron-sulfur protein 9, NDUFV1 – NADH dehydrogenase flavoprotein 1, PCK1 – 











Table 2: Gene Ontology Analysis for Differentially Expressed proteins from CHO- 
K1/DP12 F-1 conditioned media 
 
GO Term GO P-Value 
Oxidation-Reduction process BP 4.6E-11 
Response to oxidative stress BP 5.2E-5 
Mitochondrial respiratory chain complex I CC 2.0E-13 
Mitochondrion CC 1.1E-9 
Oxidative Phosphorylation KEGG 1.1E-9 
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Table 3 
































Adhesive for multilayer materials 1 NO NO 
3,3-Dimethyl-1,5-dioxacycloundecane-6,11-dione 94113-47-0 
Contamination formed in polyolefin 
containers 
1 NO NO 
3 1,2-amidododecanoic acid C12H25NO2 215.18841 693-57-2 0.56 Residue from production 1 NO NO 
4 N,N-dimethyldecan-1-amine C12H27N 185.21452 1120-24-7 0.90 Catalyst degradation product 1 NO NO 
 
5 






Propylene copolymer, residue from 
production 
1 NO YES 
Diethyl azelate 624-17-9 Plasticizer 1 NO NO 
6 
2-Propenoic acid 2-methyl- 1,2,2,6,6-pentamethyl-4- 
piperidinyl ester 
C14H25NO2 239.18838 68548-08-3 0.62 UV stabilizer 3 NO NO 
7 N-(2-hydroxyethyl)-dodecanamide C14H29NO2 243.21957 142-78-9 1.07 Antistatic agent 3 NO NO 
8 PPG n6 C18H38O7 366.26130 25322-69-4 1.23 Polymer block degradation product 3 NO NO 
9 2-Ethylhexyldiphenyl phosphate (Santicizer®) C20H27O4P 362.16400 1241-94-7 1.93 Flame retardand, plasticizer 3 NO YES 
10 cis-1,3-docosenic acid amide (Kemamide® E ultra) C22H43NO 337.33386 112-84-5 1.78 Slip agent 3 NO NO 









Polyurethane intermediate 3 YES NO 











Vinyl acetate catalyst/olefin epoxidation 

















Polyamide modification agent 3 NO NO 
Tetramethyl succinonitrile 3333-52-6 
Polymerization initiator degradation 
product 
3 NO NO 
15 1-ethenylazepan-2-one C8H13NO 139.09981 2235-00-9 0.67 Coating 3 NO NO 
16 Tris(2,4-di-tert-butylphenyl)phosphate C42H63O4P 662.44640 95906-11-9 1.22 Antioxidant degradation product 3 NA(2) NA(2) 
(1) From Toxtree using Benigni/Biossa rulebase. A = considering genotoxic effects, B = considering non-genotoxic effects. 










This article is protected by copyright. All rights reserved.
